Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
362.74
+6.61 (1.86%)
At close: Apr 28, 2026, 4:00 PM EDT
362.06
-0.68 (-0.19%)
Pre-market: Apr 29, 2026, 6:04 AM EDT
Elevance Health Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$379.94
Upside
+4.74%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $397 → $411 | Buy | Maintains | $397 → $411 | +13.30% | Apr 28, 2026 |
| Barclays | Barclays | Buy Maintains $393 → $408 | Buy | Maintains | $393 → $408 | +12.48% | Apr 24, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $396 → $399 | Strong Buy | Maintains | $396 → $399 | +10.00% | Apr 24, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $345 → $360 | Hold | Maintains | $345 → $360 | -0.76% | Apr 23, 2026 |
| Baird | Baird | Hold Maintains $317 → $331 | Hold | Maintains | $317 → $331 | -8.75% | Apr 23, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $395 → $391 | Strong Buy | Maintains | $395 → $391 | +7.79% | Apr 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $390 → $375 | Strong Buy | Maintains | $390 → $375 | +3.38% | Apr 13, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Initiates $345 | Hold | Initiates | $345 | -4.89% | Apr 8, 2026 |
| Mizuho | Mizuho | Buy Maintains $413 → $350 | Buy | Maintains | $413 → $350 | -3.51% | Mar 11, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $394 → $397 | Buy | Maintains | $394 → $397 | +9.44% | Feb 2, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $400 → $390 | Strong Buy | Maintains | $400 → $390 | +7.52% | Feb 2, 2026 |
| Barclays | Barclays | Buy Maintains $404 → $393 | Buy | Maintains | $404 → $393 | +8.34% | Jan 30, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $424 → $391 | Buy | Maintains | $424 → $391 | +7.79% | Jan 30, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $414 → $396 | Strong Buy | Maintains | $414 → $396 | +9.17% | Jan 29, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $398 → $414 | Strong Buy | Maintains | $398 → $414 | +14.13% | Jan 22, 2026 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $425 | Hold → Buy | Upgrades | $425 | +17.16% | Jan 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.